Genus plc (LON:GNS)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 2,244.00
+20.00 (0.90%)
Oct 21, 2026, 4:35 PM BST
Genus Market Cap
Genus has a market cap or net worth of 1.48 billion as of October 21, 2026. It is the 6,755th most valuable company in the world and the 171st biggest in the United Kingdom. Its market cap has decreased by 15.86% in one year.
Market Cap
1.48B
Enterprise Value
1.55B
Revenue
658.10M
Global Rank
Country Rank
#171 United Kingdom
PE Ratio
5.23
ChartMarket Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.48B, an increase of 4,680.61%. That is a compound annual growth rate of 14.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 1.48B | -14.57% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 2.04B |
| Oxford Biomedica | 630.61M |
| Avacta Group | 332.48M |
| PureTech Health | 279.01M |
| Scancell Holdings | 112.74M |
| Bioventix | 99.79M |
| 4basebio | 78.86M |
| Faron Pharmaceuticals Oy | 73.53M |